- Supported exchanges /
- ST /
- ONCOZ.ST
Oncozenge AB (ONCOZ ST) stock market data APIs
kr3.52
0.02(0.6%)
as of November 22, 2024
Price chart is built with Anychart
OncoZenge AB (publ), a pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
Oncozenge AB Financial Data Overview
| 3.275 | |
| 3.52 | |
| - | |
| 3.945 | |
| 2.94 | |
| 2.4-12.1 | |
| 47 321 K | |
| 11 713 K | |
| 4 000 | |
| -0.1502 | |
| 1.158 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'ONCOZ',
Type:
'Common Stock',
Name:
'Oncozenge AB',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
'SE0015504097',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Oncozenge AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 000
- EBITDA 7 266 K
- Earnings Per Share -0.8
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Oncozenge AB Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get Oncozenge AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
